Safeguard Scientifics, Inc (NYSE:SFE) Short Interest Update
Safeguard Scientifics, Inc (NYSE:SFE) saw a large decline in short interest in July. As of July 15th, there was short interest totalling 592,200 shares, a decline of 24.6% from the June 15th total of 785,200 shares. Approximately 2.9% of the company’s stock are sold short. Based on an average trading volume of 69,200 shares, the short-interest ratio is currently 8.6 days.
NYSE SFE traded up $0.03 on Friday, hitting $11.80. 83,452 shares of the stock were exchanged, compared to its average volume of 63,158. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.03. Safeguard Scientifics has a fifty-two week low of $7.98 and a fifty-two week high of $12.91. The firm has a market cap of $242.81 million, a P/E ratio of -15.53 and a beta of 0.88. The firm has a 50-day simple moving average of $12.04.
Safeguard Scientifics (NYSE:SFE) last issued its earnings results on Thursday, May 2nd. The asset manager reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.25. Analysts forecast that Safeguard Scientifics will post 1.37 EPS for the current fiscal year.
SFE has been the subject of several analyst reports. ValuEngine upgraded shares of Zogenix from a “buy” rating to a “strong-buy” rating in a report on Thursday, June 27th. Zacks Investment Research cut shares of GENEL ENERGY PL/ADR from a “buy” rating to a “hold” rating in a report on Tuesday, May 7th.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Read More: Benefits of owning preferred stock
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.